Department of Gastroenterology and Gastrointestinal Surgery, Hvidovre Hospital, Hvidovre, Denmark
Abdominal Center K, Bispebjerg Hospital, Kobenhavn, Denmark.
BMJ Open. 2019 Aug 21;9(8):e028999. doi: 10.1136/bmjopen-2019-028999.
Chronic pancreatitis (CP) is thought to present the end stage of a continuous disease process evolving from acute pancreatitis (AP), over recurrent AP, to early and end-stage CP. Due to the irreversible nature of CP, early detection and prevention is key. Prospective assessment based on advanced imaging modalities as well as biochemical markers of inflammation, fibrosis and oxidative stress may provide a better understanding of the underlying pathological processes and help identify novel biomarkers of disease with the ultimate goal of early diagnosis, intervention and prevention of disease progression. This paper describes the protocol of a prospective multicentre cohort study investigating the fibroinflammatory process involved in progression from acute to CP using state-of-the-art diagnostic imaging modalities and circulating biomarkers of inflammation, fibrosis and oxidative stress.
Adult control subjects and patients at different stages of CP according to the M-ANNHEIM system will be recruited from outpatient clinics at the participating sites and form three cohorts: controls (n=40), suspected CP (n=60) and definitive CP (n=60). Included patients will be followed prospectively for 15 years with advanced MRI and contrast-enhanced endoscopic ultrasound with elastography, assessment of endocrine and exocrine pancreatic function, biochemical and nutritional assessment, and evaluation of pain processing using quantitative sensory testing. Blood samples for a biobank will be obtained. The purpose of the biobank is to allow analyses of potential circulating biomarkers of disease progression, including markers of inflammation, fibrosis and oxidative stress.
Permissions from the Regional Science Ethics committee and the Regional Data Protection Agency have been obtained. We will submit the results of the study for publication in peer-reviewed journals regardless of whether the results are positive, negative or inconclusive.
慢性胰腺炎(CP)被认为是从急性胰腺炎(AP)、反复发作的 AP 到早期和终末期 CP 的连续疾病过程的终末阶段。由于 CP 的不可逆性质,早期检测和预防是关键。基于先进的成像方式以及炎症、纤维化和氧化应激的生化标志物的前瞻性评估可能会更好地了解潜在的病理过程,并有助于确定疾病的新型生物标志物,最终目标是早期诊断、干预和预防疾病进展。本文描述了一项前瞻性多中心队列研究的方案,该研究使用最新的诊断成像方式以及炎症、纤维化和氧化应激的循环生物标志物,来研究从急性到 CP 进展过程中的纤维炎症过程。
将从参与研究的各机构的门诊诊所招募成年对照组和根据 M-ANNHEIM 系统处于不同 CP 阶段的患者,并将其分为三组:对照组(n=40)、疑似 CP 组(n=60)和确诊 CP 组(n=60)。纳入的患者将进行前瞻性随访 15 年,采用先进的 MRI 和对比增强内镜超声弹性成像,评估内分泌和外分泌胰腺功能,进行生化和营养评估,并使用定量感觉测试评估疼痛处理。还将采集血样用于生物样本库。生物样本库的目的是允许分析疾病进展的潜在循环生物标志物,包括炎症、纤维化和氧化应激的标志物。
已获得区域科学伦理委员会和区域数据保护局的许可。无论结果是阳性、阴性还是不确定,我们都会将研究结果提交给同行评议的期刊发表。